CRO

The CRO (Contract Research Organization) theme includes providers of outsourced R&D and clinical services to biopharma and med‑tech sponsors. Core tracks span preclinical discovery and toxicology, clinical trial operations (Phases I–IV), site management/SMO, data management and biostatistics, central labs and imaging, regulatory/medical writing and pharmacovigilance, eClinical platforms, and real‑world evidence.The sector's total market cap is 107.50 billion USD, with a 24h change of +1.68%. Among 5 constituents, 4 are up (80.00%) and 1 are down (20.00%). The top gainer is IQVIA Holdings Inc. (IQV), with a 24h increase of +2.55%.Contract research services firm up with broad-based gains, led by quality large caps. Near term, follow leaders; medium term, align with earnings visibility and interest-rate trends.